...
search icon
inbx-img

Inhibrx Biosciences, Inc., Common Stock

INBX

NSQ

$14.43

-$0.36

(-2.43%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$216.13M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0.1278
Volume info-icon
This is the total number of shares traded during the most recent trading day.
393.15K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$10.8 L
$17.79 H
$14.43

About Inhibrx Biosciences, Inc., Common Stock

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck squamous cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California. more

Returns

Data is not properly formatted.

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue12.81M7.13M2.18M1.80M200.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":55.63,"profit":true},{"date":"2022-12-31","value":17,"profit":true},{"date":"2023-12-31","value":14.05,"profit":true},{"date":"2024-12-31","value":1.56,"profit":true}]
Cost of Revenue73.50M2.69M2.85M1.19M2.29M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":3.66,"profit":true},{"date":"2022-12-31","value":3.87,"profit":true},{"date":"2023-12-31","value":1.62,"profit":true},{"date":"2024-12-31","value":3.11,"profit":true}]
Gross Profit(60.69M)4.44M(668.00K)609.00K(2.08M)[{"date":"2020-12-31","value":-1367.75,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-15.06,"profit":false},{"date":"2023-12-31","value":13.73,"profit":true},{"date":"2024-12-31","value":-46.99,"profit":false}]
Gross Margin(473.82%)62.27%(30.67%)33.83%(1042.50%)[{"date":"2020-12-31","value":-760.87,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-49.25,"profit":false},{"date":"2023-12-31","value":54.33,"profit":true},{"date":"2024-12-31","value":-1674.06,"profit":false}]
Operating Expenses80.25M83.69M131.29M219.83M331.65M[{"date":"2020-12-31","value":24.2,"profit":true},{"date":"2021-12-31","value":25.23,"profit":true},{"date":"2022-12-31","value":39.59,"profit":true},{"date":"2023-12-31","value":66.28,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(67.44M)(76.56M)(129.12M)(219.22M)(331.45M)[{"date":"2020-12-31","value":-6744300000,"profit":false},{"date":"2021-12-31","value":-7656400000,"profit":false},{"date":"2022-12-31","value":-12911700000,"profit":false},{"date":"2023-12-31","value":-21922100000,"profit":false},{"date":"2024-12-31","value":-33144800000,"profit":false}]
Total Non-Operating Income/Expense---(40.43M)2.02B[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-2,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(75.63M)(81.77M)(145.22M)(239.72M)1.69B[{"date":"2020-12-31","value":-4.48,"profit":false},{"date":"2021-12-31","value":-4.85,"profit":false},{"date":"2022-12-31","value":-8.61,"profit":false},{"date":"2023-12-31","value":-14.21,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes3.00K2.00K3.00K3.00K2.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":66.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":66.67,"profit":true}]
Income After Taxes---(239.73M)1.69B[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-14.21,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations--(115.33M)(241.36M)1.69B[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-6.83,"profit":false},{"date":"2023-12-31","value":-14.3,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(75.64M)(81.77M)(145.23M)(241.36M)1.69B[{"date":"2020-12-31","value":-4.48,"profit":false},{"date":"2021-12-31","value":-4.85,"profit":false},{"date":"2022-12-31","value":-8.61,"profit":false},{"date":"2023-12-31","value":-14.3,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)----115.60[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

INBX
Cash Ratio 4.96
Current Ratio 5.12

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

INBX
ROA (LTM) -107.28%
ROE (LTM) 41.18%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

INBX
Debt Ratio Lower is generally better. Negative is bad. 0.61
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.39

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

INBX
Trailing PE 0.13
Forward PE NM
P/S (TTM) 1100.89
P/B 2.33
Price/FCF NM
EV/R 550.94
EV/Ebitda 0.06

FAQs

What is Inhibrx Biosciences, Inc. share price today?

Inhibrx Biosciences, Inc. (INBX) share price today is $14.43

Can Indians buy Inhibrx Biosciences, Inc. shares?

Yes, Indians can buy shares of Inhibrx Biosciences, Inc. (INBX) on Vested. To buy Inhibrx Biosciences, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in INBX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Inhibrx Biosciences, Inc. be purchased?

Yes, you can purchase fractional shares of Inhibrx Biosciences, Inc. (INBX) via the Vested app. You can start investing in Inhibrx Biosciences, Inc. (INBX) with a minimum investment of $1.

How to invest in Inhibrx Biosciences, Inc. shares from India?

You can invest in shares of Inhibrx Biosciences, Inc. (INBX) via Vested in three simple steps:

  • Click on Sign Up or Invest in INBX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Inhibrx Biosciences, Inc. shares
What is Inhibrx Biosciences, Inc. 52-week high and low stock price?

The 52-week high price of Inhibrx Biosciences, Inc. (INBX) is $17.79. The 52-week low price of Inhibrx Biosciences, Inc. (INBX) is $10.8.

What is Inhibrx Biosciences, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Inhibrx Biosciences, Inc. (INBX) is 0.1278

What is Inhibrx Biosciences, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Inhibrx Biosciences, Inc. (INBX) is 2.33

What is the Market Cap of Inhibrx Biosciences, Inc.?

The market capitalization of Inhibrx Biosciences, Inc. (INBX) is $216.13M

What is Inhibrx Biosciences, Inc.’s stock symbol?

The stock symbol (or ticker) of Inhibrx Biosciences, Inc. is INBX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top